Structure

Physi-Chem Properties

Molecular Weight:  438.35
Volume:  500.245
LogP:  7.689
LogD:  5.232
LogS:  -5.937
# Rotatable Bonds:  4
TPSA:  40.46
# H-Bond Aceptor:  2
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.468
Synthetic Accessibility Score:  4.644
Fsp3:  0.733
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.918
MDCK Permeability:  9.158390639640857e-06
Pgp-inhibitor:  0.984
Pgp-substrate:  0.009
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.574
Plasma Protein Binding (PPB):  97.32962036132812%
Volume Distribution (VD):  3.607
Pgp-substrate:  2.1891307830810547%

ADMET: Metabolism

CYP1A2-inhibitor:  0.065
CYP1A2-substrate:  0.512
CYP2C19-inhibitor:  0.282
CYP2C19-substrate:  0.932
CYP2C9-inhibitor:  0.187
CYP2C9-substrate:  0.948
CYP2D6-inhibitor:  0.53
CYP2D6-substrate:  0.712
CYP3A4-inhibitor:  0.663
CYP3A4-substrate:  0.685

ADMET: Excretion

Clearance (CL):  12.074
Half-life (T1/2):  0.027

ADMET: Toxicity

hERG Blockers:  0.272
Human Hepatotoxicity (H-HT):  0.14
Drug-inuced Liver Injury (DILI):  0.051
AMES Toxicity:  0.024
Rat Oral Acute Toxicity:  0.749
Maximum Recommended Daily Dose:  0.985
Skin Sensitization:  0.278
Carcinogencity:  0.719
Eye Corrosion:  0.003
Eye Irritation:  0.481
Respiratory Toxicity:  0.91

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471668

Natural Product ID:  NPC471668
Common Name*:   7-(Menth-1-En-4-Ol)-Ferruginol
IUPAC Name:   (4bS,8aS,10S)-10-[(4-hydroxy-4-propan-2-ylcyclohexen-1-yl)methyl]-4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol
Synonyms:  
Standard InCHIKey:  IYKBYZQSSGTINJ-WPHAXYCQSA-N
Standard InCHI:  InChI=1S/C30H46O2/c1-19(2)23-17-24-22(15-21-9-13-30(32,14-10-21)20(3)4)16-27-28(5,6)11-8-12-29(27,7)25(24)18-26(23)31/h9,17-20,22,27,31-32H,8,10-16H2,1-7H3/t22-,27+,29-,30?/m1/s1
SMILES:  CC(C)C1=C(C=C2C(=C1)C(CC3C2(CCCC3(C)C)C)CC4=CCC(CC4)(C(C)C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3091480
PubChem CID:   72724973
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18892 Salvinia molesta Species Salviniaceae Eukaryota n.a. n.a. n.a. PMID[24210499]
NPO18892 Salvinia molesta Species Salviniaceae Eukaryota whole plants east Texas, USA 2009-2011 PMID[24210499]
NPO18892 Salvinia molesta Species Salviniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens GI50 = 58410.0 nM PMID[541324]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 = 75000.0 nM PMID[541324]
NPT116 Cell Line HL-60 Homo sapiens GI50 = 48050.0 nM PMID[541324]
NPT306 Cell Line PC-3 Homo sapiens GI50 = 54190.0 nM PMID[541324]
NPT81 Cell Line A549 Homo sapiens GI50 = 62910.0 nM PMID[541324]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 87280.0 nM PMID[541324]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 60440.0 nM PMID[541324]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471668 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.973 High Similarity NPC93071
0.9554 High Similarity NPC126002
0.9537 High Similarity NPC260323
0.9537 High Similarity NPC176279
0.945 High Similarity NPC250323
0.9369 High Similarity NPC35797
0.9369 High Similarity NPC192948
0.9286 High Similarity NPC308311
0.9286 High Similarity NPC38893
0.9286 High Similarity NPC477137
0.9279 High Similarity NPC195922
0.9266 High Similarity NPC141782
0.9266 High Similarity NPC13482
0.9204 High Similarity NPC477136
0.9204 High Similarity NPC172219
0.9204 High Similarity NPC304510
0.9167 High Similarity NPC151477
0.9123 High Similarity NPC471671
0.9115 High Similarity NPC219112
0.9107 High Similarity NPC268160
0.9099 High Similarity NPC46940
0.9074 High Similarity NPC21594
0.9043 High Similarity NPC469644
0.9027 High Similarity NPC147179
0.9027 High Similarity NPC469719
0.9018 High Similarity NPC715
0.9009 High Similarity NPC95716
0.8981 High Similarity NPC117115
0.8957 High Similarity NPC154030
0.8957 High Similarity NPC206
0.8947 High Similarity NPC141001
0.8947 High Similarity NPC308828
0.8947 High Similarity NPC469663
0.8947 High Similarity NPC92
0.8929 High Similarity NPC62867
0.8929 High Similarity NPC177962
0.8909 High Similarity NPC11554
0.8889 High Similarity NPC259703
0.8889 High Similarity NPC32322
0.887 High Similarity NPC16030
0.8839 High Similarity NPC470770
0.8839 High Similarity NPC151537
0.8839 High Similarity NPC77772
0.8839 High Similarity NPC322753
0.8839 High Similarity NPC266937
0.8829 High Similarity NPC58865
0.8814 High Similarity NPC249340
0.8814 High Similarity NPC154696
0.8814 High Similarity NPC162935
0.8803 High Similarity NPC135467
0.8803 High Similarity NPC260832
0.8793 High Similarity NPC469609
0.8772 High Similarity NPC471534
0.8761 High Similarity NPC228425
0.875 High Similarity NPC132720
0.875 High Similarity NPC296683
0.8739 High Similarity NPC11250
0.8739 High Similarity NPC478058
0.8718 High Similarity NPC151197
0.8707 High Similarity NPC299180
0.8689 High Similarity NPC108164
0.8684 High Similarity NPC322239
0.8684 High Similarity NPC317869
0.8673 High Similarity NPC469912
0.8667 High Similarity NPC471187
0.8661 High Similarity NPC314187
0.8611 High Similarity NPC211885
0.8607 High Similarity NPC43000
0.8607 High Similarity NPC100414
0.8607 High Similarity NPC325294
0.8607 High Similarity NPC321822
0.8596 High Similarity NPC471179
0.8595 High Similarity NPC181334
0.8583 High Similarity NPC71094
0.8583 High Similarity NPC297057
0.8583 High Similarity NPC176208
0.8571 High Similarity NPC241001
0.8559 High Similarity NPC271274
0.8537 High Similarity NPC471077
0.8532 High Similarity NPC252105
0.8525 High Similarity NPC137750
0.8525 High Similarity NPC124030
0.8522 High Similarity NPC263753
0.85 High Similarity NPC253627
0.8487 Intermediate Similarity NPC99734
0.8482 Intermediate Similarity NPC320439
0.8475 Intermediate Similarity NPC48342
0.8475 Intermediate Similarity NPC164649
0.8468 Intermediate Similarity NPC219286
0.8468 Intermediate Similarity NPC99557
0.8462 Intermediate Similarity NPC154511
0.8462 Intermediate Similarity NPC474358
0.8462 Intermediate Similarity NPC247858
0.8462 Intermediate Similarity NPC474387
0.8462 Intermediate Similarity NPC137496
0.8462 Intermediate Similarity NPC257540
0.844 Intermediate Similarity NPC225506
0.844 Intermediate Similarity NPC72729
0.843 Intermediate Similarity NPC121168
0.843 Intermediate Similarity NPC471794
0.843 Intermediate Similarity NPC152946
0.8417 Intermediate Similarity NPC328504
0.8403 Intermediate Similarity NPC42657
0.8393 Intermediate Similarity NPC53740
0.8393 Intermediate Similarity NPC155072
0.8387 Intermediate Similarity NPC84672
0.8387 Intermediate Similarity NPC69424
0.8387 Intermediate Similarity NPC72667
0.8387 Intermediate Similarity NPC176130
0.8387 Intermediate Similarity NPC78364
0.8378 Intermediate Similarity NPC272029
0.8378 Intermediate Similarity NPC238696
0.8376 Intermediate Similarity NPC84999
0.8376 Intermediate Similarity NPC246760
0.8374 Intermediate Similarity NPC4286
0.8374 Intermediate Similarity NPC76119
0.8362 Intermediate Similarity NPC321589
0.8361 Intermediate Similarity NPC198014
0.8349 Intermediate Similarity NPC33675
0.8349 Intermediate Similarity NPC299762
0.8349 Intermediate Similarity NPC122005
0.8349 Intermediate Similarity NPC252821
0.8347 Intermediate Similarity NPC474115
0.8333 Intermediate Similarity NPC108129
0.8333 Intermediate Similarity NPC477037
0.8333 Intermediate Similarity NPC318581
0.8333 Intermediate Similarity NPC318552
0.8333 Intermediate Similarity NPC190501
0.8333 Intermediate Similarity NPC478121
0.8333 Intermediate Similarity NPC325544
0.832 Intermediate Similarity NPC201069
0.8319 Intermediate Similarity NPC27252
0.8319 Intermediate Similarity NPC472980
0.8319 Intermediate Similarity NPC472979
0.8306 Intermediate Similarity NPC254492
0.8305 Intermediate Similarity NPC312105
0.8305 Intermediate Similarity NPC261973
0.8304 Intermediate Similarity NPC138942
0.8304 Intermediate Similarity NPC47284
0.8293 Intermediate Similarity NPC199273
0.8291 Intermediate Similarity NPC107240
0.8291 Intermediate Similarity NPC249270
0.8288 Intermediate Similarity NPC168829
0.8288 Intermediate Similarity NPC269212
0.8268 Intermediate Similarity NPC243305
0.8261 Intermediate Similarity NPC224870
0.8257 Intermediate Similarity NPC79241
0.8257 Intermediate Similarity NPC6597
0.8257 Intermediate Similarity NPC77492
0.8254 Intermediate Similarity NPC171460
0.8254 Intermediate Similarity NPC303910
0.8254 Intermediate Similarity NPC276238
0.825 Intermediate Similarity NPC323074
0.825 Intermediate Similarity NPC176893
0.8241 Intermediate Similarity NPC144682
0.8241 Intermediate Similarity NPC222146
0.824 Intermediate Similarity NPC186889
0.824 Intermediate Similarity NPC476536
0.823 Intermediate Similarity NPC469913
0.823 Intermediate Similarity NPC310456
0.8226 Intermediate Similarity NPC87985
0.822 Intermediate Similarity NPC474486
0.8214 Intermediate Similarity NPC288411
0.8205 Intermediate Similarity NPC117846
0.8203 Intermediate Similarity NPC85595
0.8203 Intermediate Similarity NPC321086
0.8198 Intermediate Similarity NPC477685
0.8198 Intermediate Similarity NPC51015
0.8197 Intermediate Similarity NPC142198
0.8197 Intermediate Similarity NPC77569
0.8182 Intermediate Similarity NPC103916
0.8182 Intermediate Similarity NPC68339
0.8182 Intermediate Similarity NPC92730
0.8175 Intermediate Similarity NPC47288
0.8174 Intermediate Similarity NPC186385
0.8174 Intermediate Similarity NPC299568
0.8165 Intermediate Similarity NPC312132
0.8165 Intermediate Similarity NPC259512
0.816 Intermediate Similarity NPC71610
0.8151 Intermediate Similarity NPC115808
0.8145 Intermediate Similarity NPC224342
0.8145 Intermediate Similarity NPC265413
0.8145 Intermediate Similarity NPC248557
0.8145 Intermediate Similarity NPC10154
0.8142 Intermediate Similarity NPC243601
0.814 Intermediate Similarity NPC49742
0.814 Intermediate Similarity NPC476282
0.813 Intermediate Similarity NPC321402
0.8125 Intermediate Similarity NPC108497
0.8125 Intermediate Similarity NPC312341
0.8125 Intermediate Similarity NPC19856
0.8125 Intermediate Similarity NPC471851
0.812 Intermediate Similarity NPC166995
0.812 Intermediate Similarity NPC302371
0.8115 Intermediate Similarity NPC164852
0.8115 Intermediate Similarity NPC129176
0.8099 Intermediate Similarity NPC258366
0.8099 Intermediate Similarity NPC31296
0.8099 Intermediate Similarity NPC79933
0.8099 Intermediate Similarity NPC473974

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471668 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8596 High Similarity NPD7635 Approved
0.8487 Intermediate Similarity NPD4059 Approved
0.8482 Intermediate Similarity NPD2342 Discontinued
0.8475 Intermediate Similarity NPD3091 Approved
0.8333 Intermediate Similarity NPD2932 Approved
0.8333 Intermediate Similarity NPD3019 Approved
0.8241 Intermediate Similarity NPD1809 Phase 2
0.8197 Intermediate Similarity NPD3092 Approved
0.8182 Intermediate Similarity NPD3020 Approved
0.8174 Intermediate Similarity NPD4750 Phase 3
0.8165 Intermediate Similarity NPD288 Approved
0.8073 Intermediate Similarity NPD844 Approved
0.8033 Intermediate Similarity NPD3095 Discontinued
0.7982 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD5736 Approved
0.7946 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD3094 Phase 2
0.7909 Intermediate Similarity NPD2859 Approved
0.7909 Intermediate Similarity NPD2860 Approved
0.789 Intermediate Similarity NPD845 Approved
0.7886 Intermediate Similarity NPD2286 Discontinued
0.7863 Intermediate Similarity NPD3022 Approved
0.7863 Intermediate Similarity NPD3021 Approved
0.7818 Intermediate Similarity NPD2933 Approved
0.7818 Intermediate Similarity NPD2934 Approved
0.7805 Intermediate Similarity NPD4093 Discontinued
0.7803 Intermediate Similarity NPD4097 Suspended
0.7778 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7752 Intermediate Similarity NPD2605 Approved
0.7752 Intermediate Similarity NPD2606 Approved
0.7742 Intermediate Similarity NPD1751 Approved
0.7734 Intermediate Similarity NPD4624 Approved
0.7731 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7717 Intermediate Similarity NPD6696 Suspended
0.771 Intermediate Similarity NPD6663 Approved
0.7705 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD5156 Approved
0.7692 Intermediate Similarity NPD5155 Approved
0.768 Intermediate Similarity NPD3026 Approved
0.768 Intermediate Similarity NPD3023 Approved
0.7661 Intermediate Similarity NPD3024 Approved
0.7661 Intermediate Similarity NPD3025 Approved
0.7634 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7615 Intermediate Similarity NPD3594 Approved
0.7615 Intermediate Similarity NPD3595 Approved
0.7603 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD4626 Approved
0.7597 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD7340 Approved
0.7557 Intermediate Similarity NPD4625 Phase 3
0.7538 Intermediate Similarity NPD3636 Approved
0.7538 Intermediate Similarity NPD3635 Approved
0.7538 Intermediate Similarity NPD3637 Approved
0.7519 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7519 Intermediate Similarity NPD3620 Phase 2
0.75 Intermediate Similarity NPD4749 Approved
0.75 Intermediate Similarity NPD5327 Phase 3
0.7462 Intermediate Similarity NPD2194 Approved
0.7462 Intermediate Similarity NPD2195 Approved
0.746 Intermediate Similarity NPD4589 Approved
0.7459 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD2234 Approved
0.7459 Intermediate Similarity NPD2229 Approved
0.7459 Intermediate Similarity NPD2228 Approved
0.7445 Intermediate Similarity NPD4725 Approved
0.7445 Intermediate Similarity NPD4721 Approved
0.7445 Intermediate Similarity NPD4726 Approved
0.7426 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7426 Intermediate Similarity NPD7742 Approved
0.7426 Intermediate Similarity NPD7743 Approved
0.7417 Intermediate Similarity NPD1792 Phase 2
0.7414 Intermediate Similarity NPD940 Approved
0.7414 Intermediate Similarity NPD846 Approved
0.7407 Intermediate Similarity NPD6353 Approved
0.7398 Intermediate Similarity NPD497 Approved
0.7385 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD1201 Approved
0.7344 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD6671 Approved
0.7333 Intermediate Similarity NPD5735 Approved
0.7317 Intermediate Similarity NPD1398 Phase 1
0.7317 Intermediate Similarity NPD496 Approved
0.7317 Intermediate Similarity NPD495 Approved
0.7317 Intermediate Similarity NPD498 Approved
0.7302 Intermediate Similarity NPD7330 Discontinued
0.7302 Intermediate Similarity NPD5303 Approved
0.7302 Intermediate Similarity NPD5304 Approved
0.7286 Intermediate Similarity NPD7003 Approved
0.7286 Intermediate Similarity NPD8166 Discontinued
0.7259 Intermediate Similarity NPD4140 Approved
0.7259 Intermediate Similarity NPD4060 Phase 1
0.7246 Intermediate Similarity NPD5404 Approved
0.7246 Intermediate Similarity NPD5406 Approved
0.7246 Intermediate Similarity NPD5408 Approved
0.7246 Intermediate Similarity NPD6099 Approved
0.7246 Intermediate Similarity NPD5405 Approved
0.7246 Intermediate Similarity NPD6100 Approved
0.7244 Intermediate Similarity NPD5691 Approved
0.7239 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD1242 Phase 1
0.7176 Intermediate Similarity NPD1283 Approved
0.7174 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD1444 Approved
0.7167 Intermediate Similarity NPD1445 Approved
0.7165 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD111 Approved
0.7143 Intermediate Similarity NPD7636 Approved
0.7133 Intermediate Similarity NPD7390 Discontinued
0.7133 Intermediate Similarity NPD7041 Phase 2
0.7133 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD1470 Approved
0.7113 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD4235 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7109 Intermediate Similarity NPD1651 Approved
0.7092 Intermediate Similarity NPD3638 Discontinued
0.709 Intermediate Similarity NPD4908 Phase 1
0.7083 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8032 Phase 2
0.7042 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7095 Approved
0.7023 Intermediate Similarity NPD2232 Approved
0.7023 Intermediate Similarity NPD2233 Approved
0.7023 Intermediate Similarity NPD2230 Approved
0.7015 Intermediate Similarity NPD2861 Phase 2
0.7014 Intermediate Similarity NPD2420 Approved
0.7014 Intermediate Similarity NPD2421 Approved
0.7 Intermediate Similarity NPD3143 Discontinued
0.6984 Remote Similarity NPD5951 Approved
0.6972 Remote Similarity NPD6674 Discontinued
0.6966 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6947 Remote Similarity NPD1281 Approved
0.6923 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6917 Remote Similarity NPD9500 Approved
0.6917 Remote Similarity NPD8651 Approved
0.6905 Remote Similarity NPD5283 Phase 1
0.6901 Remote Similarity NPD7037 Approved
0.6901 Remote Similarity NPD4257 Approved
0.6901 Remote Similarity NPD4256 Phase 2
0.6899 Remote Similarity NPD7741 Discontinued
0.6894 Remote Similarity NPD3070 Discontinued
0.6891 Remote Similarity NPD3028 Approved
0.6884 Remote Similarity NPD3109 Approved
0.6884 Remote Similarity NPD3110 Approved
0.6875 Remote Similarity NPD8131 Suspended
0.6875 Remote Similarity NPD405 Clinical (unspecified phase)
0.687 Remote Similarity NPD2688 Clinical (unspecified phase)
0.6861 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6861 Remote Similarity NPD7294 Phase 1
0.6853 Remote Similarity NPD5698 Clinical (unspecified phase)
0.685 Remote Similarity NPD1793 Approved
0.685 Remote Similarity NPD1791 Approved
0.6849 Remote Similarity NPD3645 Discontinued
0.6842 Remote Similarity NPD1669 Approved
0.6835 Remote Similarity NPD3657 Discovery
0.6828 Remote Similarity NPD3300 Phase 2
0.6822 Remote Similarity NPD7644 Approved
0.6818 Remote Similarity NPD1610 Phase 2
0.6818 Remote Similarity NPD1611 Approved
0.6815 Remote Similarity NPD6584 Phase 3
0.6797 Remote Similarity NPD709 Approved
0.6797 Remote Similarity NPD7157 Approved
0.6794 Remote Similarity NPD7725 Approved
0.6794 Remote Similarity NPD2668 Approved
0.6794 Remote Similarity NPD2667 Approved
0.6794 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6779 Remote Similarity NPD7458 Discontinued
0.6765 Remote Similarity NPD4208 Discontinued
0.6763 Remote Similarity NPD6346 Approved
0.6746 Remote Similarity NPD228 Approved
0.6739 Remote Similarity NPD2028 Clinical (unspecified phase)
0.6736 Remote Similarity NPD2211 Approved
0.6736 Remote Similarity NPD2209 Approved
0.672 Remote Similarity NPD5451 Approved
0.6719 Remote Similarity NPD1476 Clinical (unspecified phase)
0.6689 Remote Similarity NPD6273 Approved
0.6689 Remote Similarity NPD6090 Discontinued
0.6667 Remote Similarity NPD6387 Discontinued
0.6667 Remote Similarity NPD4198 Discontinued
0.6667 Remote Similarity NPD2157 Approved
0.6643 Remote Similarity NPD2979 Phase 3
0.6643 Remote Similarity NPD2238 Phase 2
0.6642 Remote Similarity NPD4212 Discontinued
0.6619 Remote Similarity NPD3764 Approved
0.6618 Remote Similarity NPD1164 Approved
0.6618 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6618 Remote Similarity NPD4103 Phase 2
0.6617 Remote Similarity NPD1980 Approved
0.6617 Remote Similarity NPD1983 Approved
0.6617 Remote Similarity NPD1981 Approved
0.661 Remote Similarity NPD6048 Clinical (unspecified phase)
0.661 Remote Similarity NPD6049 Phase 2
0.6601 Remote Similarity NPD5929 Approved
0.6599 Remote Similarity NPD3845 Phase 1
0.6599 Remote Similarity NPD2422 Clinical (unspecified phase)
0.6597 Remote Similarity NPD5763 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data